October 2004 Archives - Silence Therapeutics

News	Events
Publications	Companies
Clinical Trials

Lene Worsaae Dalby appointed VP Clinical Development
0 Replies

October 04, 2004

Copenhagen, 4 October 2004 Santaris Pharma A/S, the Danish biopharmaceutical company developing innovative gen-targeting drugs for the treatment of cancer, today announced the appointment of Dr Lene Worsaae Dalby as Vice President of Clinical Development. read more Contine Reading & Discuss→

Posted in Companies | Tagged in | Santaris Posted in News | Tagged in | Santaris Posted in Other News | Tagged in | Santaris Posted in Syndicated | Tagged in | Santaris